In contrast, BRAFV600E/K positive melanoma cells tend to express undetectable or low levels of most RTKs, most likely because the strong endogenous MAPK activation by mutant BRAF selects against active RTK signaling to avoid senescence10. This evidence concerns the gene BRAF and melanoma.